Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity in neuromuscular disease.

J Newsom-Davis1

  • 1University of Oxford, Department of Clinical Neurology, Radcliffe Infirmary, England.

Annals of the New York Academy of Sciences
|January 1, 1988
PubMed
Summary

Investigating autoimmune diseases reveals challenges like antigen heterogeneity and detection limits. Only Myasthenia Gravis with anti-acetylcholine receptor antibodies fully meets criteria for pathogenic antibodies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Receptors, antibodies and disease.

Immunology today·2014
Same author

Voluntary partial retraction of: Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes.

Neurology·2009
Same author

The emerging diversity of neuromuscular junction disorders.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2007
Same author

Treatment for Lambert-Eaton myasthenic syndrome.

The Cochrane database of systematic reviews·2005
Same author

Neuromyotonia.

Revue neurologique·2004
Same author

Distinct phenotypes of congenital acetylcholine receptor deficiency.

Neuromuscular disorders : NMD·2004

Area of Science:

  • Neurology
  • Immunology
  • Autoimmune Diseases

Background:

  • Autoimmune mechanisms in neurological disorders are complex and challenging to study.
  • Confounding factors can obscure the identification of pathogenic antibodies and disease processes.

Purpose of the Study:

  • To review and analyze the challenges in establishing autoimmune mechanisms in neurological disorders.
  • To assess the evidence for pathogenic antibodies in various autoimmune conditions based on established postulates.

Main Methods:

  • Literature review and analysis of existing data on autoimmune neurological disorders.
  • Evaluation of evidence against established criteria for autoimmunity, including antigen identification, antibody detection, passive transfer, and animal models.

Main Results:

  • Myasthenia Gravis (MG) with anti-acetylcholine receptor (AChR) antibodies is the only condition reviewed that fully meets all postulates for autoimmunity.
  • Lambert-Eaton myasthenic syndrome (LEMS) and IgM kappa anti-MAG demyelinating neuropathy have known antigens but lack defined epitopes and animal models.
  • Evidence for autoimmunity is less complete in Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) due to unknown antigens.

Conclusions:

  • Establishing definitive autoimmune mechanisms requires rigorous evidence, including meeting all established postulates.
  • Heterogeneity in disease presentation, antigen detection, and antibody cross-reactivity pose significant challenges.
  • Further research is needed to fully elucidate autoimmune mechanisms in many neurological disorders, particularly demyelinating neuropathies.

Related Experiment Videos